Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesús Funuyet-Salas

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Psychosomatic Research|September 29, 2022
Vitality, mental health and role-physical mediate the influence of coping on depressive symptoms and self-efficacy in patients with non-alcoholic fatty liver disease: A cross-sectional studyJesús Funuyet-Salas, María Ángeles Pérez-San-Gregorio, Agustín Martín-Rodríguez, et al.
Journal of Clinical Medicine|June 2, 2021
Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation ModelJesús Funuyet-Salas, Agustín Martín-Rodríguez, María Ángeles Pérez-San-Gregorio, et al.
Frontiers in Medicine|November 16, 2020
Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver DiseaseJesús Funuyet-Salas, María Ángeles Pérez-San-Gregorio, Agustín Martín-Rodríguez, et al.
International Journal of Environmental Research and Public Health|April 3, 2021
Quality of Life and Coping in Nonalcoholic Fatty Liver Disease: Influence of Diabetes and ObesityJesús Funuyet-Salas, María Ángeles Pérez-San-Gregorio, Agustín Martín-Rodríguez, et al.
Healthcare (Basel, Switzerland)|May 27, 2023
Significance of Post-Traumatic Growth and Mental Health for Coping in Multiple Sclerosis CaregiversIrene Gil-González, María Ángeles Pérez-San-Gregorio, Jesús Funuyet-Salas, et al.
Plos One|May 6, 2024
Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United KingdomJesús Funuyet-Salas, Agustín Martín-Rodríguez, María Ángeles Pérez-San-Gregorio, et al.
Scientific Reports|September 17, 2024
Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosisMaurice Michel, Jesús Funuyet-Salas, Michelle Doll, et al.
Alimentary Pharmacology & Therapeutics|July 27, 2023
Editorial: Feeling better about NASH-Authors' replyManuel Romero-Gómez, Matthew J Armstrong, Jesús Funuyet-Salas, et al.
Expert Review of Gastroenterology & Hepatology|December 2, 2025
Highlighting the relevance of a multidisciplinary approach in metabolic-asociated steatotic liver disease (MASLD)Carmen Lara-Romero, Miguel Angel Fernández-Gómez, Franz Martín, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2023
Improved health-related quality of life with semaglutide in people with non-alcoholic steatohepatitis: A randomised trialManuel Romero-Gómez, Matthew J Armstrong, Jesús Funuyet-Salas, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Psychosomatic Research|September 29, 2022
Vitality, mental health and role-physical mediate the influence of coping on depressive symptoms and self-efficacy in patients with non-alcoholic fatty liver disease: A cross-sectional studyJesús Funuyet-Salas, María Ángeles Pérez-San-Gregorio, Agustín Martín-Rodríguez, et al.
Journal of Clinical Medicine|June 2, 2021
Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation ModelJesús Funuyet-Salas, Agustín Martín-Rodríguez, María Ángeles Pérez-San-Gregorio, et al.
Frontiers in Medicine|November 16, 2020
Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver DiseaseJesús Funuyet-Salas, María Ángeles Pérez-San-Gregorio, Agustín Martín-Rodríguez, et al.
International Journal of Environmental Research and Public Health|April 3, 2021
Quality of Life and Coping in Nonalcoholic Fatty Liver Disease: Influence of Diabetes and ObesityJesús Funuyet-Salas, María Ángeles Pérez-San-Gregorio, Agustín Martín-Rodríguez, et al.
Healthcare (Basel, Switzerland)|May 27, 2023
Significance of Post-Traumatic Growth and Mental Health for Coping in Multiple Sclerosis CaregiversIrene Gil-González, María Ángeles Pérez-San-Gregorio, Jesús Funuyet-Salas, et al.
Plos One|May 6, 2024
Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United KingdomJesús Funuyet-Salas, Agustín Martín-Rodríguez, María Ángeles Pérez-San-Gregorio, et al.
Scientific Reports|September 17, 2024
Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosisMaurice Michel, Jesús Funuyet-Salas, Michelle Doll, et al.
Alimentary Pharmacology & Therapeutics|July 27, 2023
Editorial: Feeling better about NASH-Authors' replyManuel Romero-Gómez, Matthew J Armstrong, Jesús Funuyet-Salas, et al.
Expert Review of Gastroenterology & Hepatology|December 2, 2025
Highlighting the relevance of a multidisciplinary approach in metabolic-asociated steatotic liver disease (MASLD)Carmen Lara-Romero, Miguel Angel Fernández-Gómez, Franz Martín, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2023
Improved health-related quality of life with semaglutide in people with non-alcoholic steatohepatitis: A randomised trialManuel Romero-Gómez, Matthew J Armstrong, Jesús Funuyet-Salas, et al.
Pageof 2